Thermo Fisher's 2025 headwinds from tariffs and US research funding cuts are real but temporary. Read why TMO stock is a ...

Danaher Corporation (NYSE:DHR) and AstraZeneca PLC (NASDAQ:AZN) have announced a major partnership to accelerate the ...

Danaher Corp. closed 32.84% short of its 52-week high of $281.70, which the company reached on August 1st.

DHR and AstraZeneca team up to develop AI-powered diagnostics, aiming to boost precision medicine by improving patient ...

Danaher Corporation has announced a collaboration with AstraZeneca for diagnostic tools and tests development and ...

Danaher Corp. closed 34.49% below its 52-week high of $281.70, which the company achieved on August 1st.

Shares of Danaher Corp. slipped 5.54% to $186.81 Wednesday, on what proved to be an all-around poor trading session for the ...

Danaher Corp on Thursday said it has entered a partnership with AstraZeneca PLC to develop and commercialise tools and tests for precision medicine treatments, including artificial intelligence ...

DHR gains from strength across its businesses, acquired assets and shareholder-friendly policies. High long-term debt remains concerning.

In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other stocks that Jim Cramer discusses. Back in 2024, on May 15, Mad Money’s Jim Cramer ...

In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other billionaire Lei Zhang’s stock picks with huge upside potential. Lei Zhang, the founder ...

Danaher Corporation's intrinsic value is estimated at $213 per share, suggesting a 14% upside from the current price of $187, with a 12% margin of safety. Despite revenue growth driven by ...